600557 康緣藥業
按盤價 
12.750 -0.060 (-0.468%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.133 | 10.792 | 9.592 | 7.568 | 6.490 |
| 總資產報酬率 ROA (%) | 3.746 | 7.715 | 6.781 | 5.282 | 4.300 |
| 投入資產回報率 ROIC (%) | 5.102 | 10.504 | 9.063 | 6.873 | 5.626 | 邊際利潤分析 |
| 銷售毛利率 (%) | 74.545 | 74.269 | 72.096 | 71.906 | 72.899 |
| 營業利潤率 (%) | 13.829 | 11.582 | 10.453 | 9.620 | 11.591 |
| 息稅前利潤/營業總收入 (%) | 13.225 | 10.845 | 10.041 | 9.222 | 10.449 |
| 淨利潤/營業總收入 (%) | 12.005 | 11.238 | 10.157 | 8.890 | 9.038 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 83.178 | 92.179 | 91.827 | 94.374 | 103.978 |
| 價值變動淨收益/利潤總額(%) | 1.930 | 2.685 | 0.942 | 1.236 | 0.921 |
| 營業外收支淨額/利潤總額(%) | 1.358 | -2.325 | -2.040 | -6.920 | -19.359 | 償債能力分析 |
| 流動比率 (X) | 2.500 | 2.517 | 2.094 | 1.978 | 1.701 |
| 速動比率 (X) | 2.177 | 2.300 | 1.902 | 1.746 | 1.479 |
| 資產負債率 (%) | 24.365 | 24.402 | 27.396 | 25.678 | 29.285 |
| 帶息債務/全部投入資本 (%) | -2.669 | -1.613 | 2.969 | 4.527 | 9.736 |
| 股東權益/帶息債務 (%) | -3,732.036 | -6,149.795 | 3,213.404 | 2,064.423 | 906.257 |
| 股東權益/負債合計 (%) | 299.552 | 298.992 | 255.353 | 278.546 | 232.540 |
| 利息保障倍數 (X) | -16.635 | -22.894 | -49.439 | 41.010 | 14.152 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 52.086 | 51.103 | 60.413 | 83.245 | 119.504 |
| 存貨周轉天數 (天) | 133.559 | 99.581 | 100.950 | 125.488 | 142.622 |
| 備註： | 即時報價更新時間為 23/08/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
